Graeber W
Klin Monbl Augenheilkd. 1983 Apr;182(4):265-8. doi: 10.1055/s-2008-1054761.
Choyce Mark IX lenses were implanted in 72 patients between 71 and 86 years of age suffering from unilateral aphakia, who could not be helped with contact lenses; 38 of the patients were observed for a period of more than 16 months. The lenses were attached in the angle of the anterior chamber. None of the patients showed signs of the previously feared complications such as corneal decompensation, secondary glaucoma or iridocyclitis. The Choyce lens is ideally suited for secondary implantation. The operation is simple and post-operative reactions disappear in less than a week. The lens sits firmly in the eye; it cannot be dislodged against the endothelium of the cornea. The pupil is dilatable and its condition is unimportant. There is no contraindication for implantation in cases in which vitreous is present in the anterior chamber. The marked subjective improvement, which all the patients remarked on, is especially worth noting.
将乔伊斯九号人工晶状体植入72例年龄在71至86岁之间的单侧无晶状体患者体内，这些患者无法佩戴隐形眼镜；其中38例患者被观察了超过16个月。人工晶状体被固定在前房角。没有患者出现之前担心的并发症迹象，如角膜失代偿、继发性青光眼或虹膜睫状体炎。乔伊斯人工晶状体非常适合二期植入。手术简单，术后反应在不到一周内消失。人工晶状体在眼内固定牢固；不会抵靠角膜内皮移位。瞳孔可扩张，其状况无关紧要。前房有玻璃体的病例中植入人工晶状体没有禁忌证。所有患者都提到的明显主观改善尤其值得注意。
